We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Asure Software
ASUR
$226M
| $231K | ﹤0.01% |
26,000
| – | – |
|
802
Kimco Realty
KIM
$17.8B
| $227K | ﹤0.01% |
10,900
-2,500
| -19% | -$51.8K |
|
803
Li Auto
LI
$13.1B
| $226K | ﹤0.01% |
+6,473
| New | +$152K |
|
|
GOOD
804
Gladstone Commercial Corp
GOOD
$628M
| $225K | ﹤0.01% |
9,980
-20
| -0.2% | -$427 |
|
805
Goodyear
GT
$2.03B
| $223K | ﹤0.01% |
13,031
| – | – |
|
806
Trade Desk
TTD
$8.57B
| $221K | ﹤0.01% |
+2,860
| New | +$183K |
|
807
Riot Platforms
RIOT
$8.15B
| $220K | ﹤0.01% |
+5,840
| New | +$209K |
|
808
Andersons Inc
ANDE
$2.51B
| $213K | ﹤0.01% |
+6,973
| New | +$210K |
|
|
CLR
809
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $209K | ﹤0.01% |
+5,506
| New | +$171K |
|
|
PBCT
810
DELISTED
People's United Financial Inc
PBCT
| $208K | ﹤0.01% |
12,163
| – | – |
|
811
Gold Fields
GFI
$29.3B
| $196K | ﹤0.01% |
22,021
-10,788
| -33% | -$112K |
|
812
CEMIG Preferred Shares
CIG
$6.15B
| $188K | ﹤0.01% |
133,229
-62,207
| -32% | -$85.9K |
|
813
BlackBerry
BB
$4.92B
| $183K | ﹤0.01% |
15,000
-7,191
| -32% | -$75.3K |
|
|
AUY
814
DELISTED
Yamana Gold, Inc.
AUY
| $145K | ﹤0.01% |
34,308
+16,035
| +88% | +$77.7K |
|
|
QCLS
815
Q/C Technologies Inc
QCLS
$25.7M
| $114K | ﹤0.01% |
6
| – | – |
|
816
Telefônica Brasil
VIV
$22.6B
| $111K | ﹤0.01% |
+13,078
| New | +$110K |
|
|
CHMA
817
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $111K | ﹤0.01% |
23,500
| – | – |
|
818
Fortress Biotech
FBIO
$108M
| $80K | ﹤0.01% |
1,500
| – | – |
|
819
MannKind Corp
MNKD
$1.26B
| $63K | ﹤0.01% |
+11,500
| New | +$49.8K |
|
|
AGRX
820
DELISTED
Agile Therapeutics
AGRX
| $39K | ﹤0.01% |
+15
| New | +$49.5K |
|
821
Perspective Therapeutics
CATX
$333M
| $28K | ﹤0.01% |
+3,488
| New | +$30.5K |
|
|
RNTX
822
Rein Therapeutics
RNTX
$66.6M
| $28K | ﹤0.01% |
+1,128
| New | +$28.1K |
|
823
Genmab
GMAB
$17.8B
| $6K | ﹤0.01% |
136
-76,313
| -100% | -$2.94M |
|
824
Toyota
TM
$214B
| $6K | ﹤0.01% |
37
+1
| +3% | +$164 |
|
825
Aptiv
APTV
$12B
| $5K | ﹤0.01% |
31
-1
| -3% | -$147 |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.